Gladstone Institutes at SfN 2026

Nov 14–18, 2026 Washington, DC ~21k attendees Website

Gladstone Institutes brings 5 presentations to SfN 2026 in Washington. Its presentations at this meeting centre on Alzheimer’s disease models, neuronal circuit disruption and ways to restore brain function. One thread examines whether blocking fibrin can reduce neuronal hyperactivity and restore neuroimmune interactions and decision-making.

Organization	SfN 2026 Attendance
Gladstone Institutes San Francisco, CA
gladstone.org Universities and research institutes Independent biomedical research institute in San Francisco, California.	Talk Sat Nov 14 1:45–2pm Part of Session NANO01: Alzheimer's Disease Therapeutic Strategies: Amyloid, Tau, and Metabolism Tau reduction counteracts transcriptomic and behavioral abnormalities in an Alzheimer amyloid model WCC Rm 145 Lecture Sat Nov 14 3–4pm Part of Session LEC03: SfNova Lecture Towards Solving the Blood-Brain Barrier WCC Hall D Poster Sun Nov 15 8am–noon Part of Session PSTR050: Synaptic Alterations in Alzheimer's Disease Partial reduction of GIRK1 rescues interneuron function and reduces network hypersynchrony in an Alzheimer’s disease mouse model WCC Halls A-C · Board V5 Talk Mon Nov 16 8:30–8:45am Part of Session NANO17: Alzheimer's Disease Therapeutic Strategies: Other Resilience to neuronal hyperactivity and restoration of the neuroimmune interactome and decision-making by blocking fibrin in a model of Alzheimer’s disease WCC Rm 146C Poster Tue Nov 17 1–5pm Part of Session PSTR260: Alzheimer's Disease: Neural Circuit Disruption II VAME-Based Behavioral Segmentation Reveals Functional Clustering of GABAergic Interneurons in Health and Their Disruption in Alzheimer's Disease Mouse Models WCC Halls A-C · Board U15

Organization

SfN 2026 Attendance

Gladstone Institutes

San Francisco, CA

gladstone.org

Universities and research institutes

Independent biomedical research institute in San Francisco, California.

Talk

Sat Nov 14
1:45–2pm

Part of Session NANO01: Alzheimer's Disease Therapeutic Strategies: Amyloid, Tau, and Metabolism

Tau reduction counteracts transcriptomic and behavioral abnormalities in an Alzheimer amyloid model

WCC Rm 145

Lecture

Sat Nov 14
3–4pm

Part of Session LEC03: SfNova Lecture

Towards Solving the Blood-Brain Barrier

WCC Hall D

Poster

Sun Nov 15
8am–noon

Part of Session PSTR050: Synaptic Alterations in Alzheimer's Disease

Partial reduction of GIRK1 rescues interneuron function and reduces network hypersynchrony in an Alzheimer’s disease mouse model

WCC Halls A-C · Board V5

Talk

Mon Nov 16
8:30–8:45am

Part of Session NANO17: Alzheimer's Disease Therapeutic Strategies: Other

Resilience to neuronal hyperactivity and restoration of the neuroimmune interactome and decision-making by blocking fibrin in a model of Alzheimer’s disease

WCC Rm 146C

Poster

Tue Nov 17
1–5pm

Part of Session PSTR260: Alzheimer's Disease: Neural Circuit Disruption II

VAME-Based Behavioral Segmentation Reveals Functional Clustering of GABAergic Interneurons in Health and Their Disruption in Alzheimer's Disease Mouse Models

WCC Halls A-C · Board U15

Instantly find 20 buyers from Gladstone Institutes

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Society for Neuroscience. Organization details are derived from SfN’s published exhibitor list, its Neuroscience Meeting Planner and each organization’s own website. Submit a correction